Login / Signup

Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application.

Afsaneh SadremomtazAmeena M AliForoozan JouyandehSaeed BalalaieRazieh NavariSylvain BroussyKamran MansouriMatthew R GrovesS Mohsen Asghari
Published in: Signal transduction and targeted therapy (2020)
Keyphrases
  • vascular endothelial growth factor
  • molecular docking
  • molecular dynamics simulations
  • endothelial cells
  • cancer therapy
  • binding protein